Cargando…

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2)

Background: Stanniocalcin-2 (STC2) is a secreted glycoprotein which plays an important role in regulating the homeostasis of calcium, glucose homeostasis, and phosphorus metastasis. Accumulating evidence suggests that STC2 is implicated in cancer mechanisms. However, the effects of STC2 on cancer de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Zhong-Hui, Shen, Xianfeng, Wei, Yanhong, Chen, Yongji, Chai, Hongbo, Xia, Lingyun, Leng, Weidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354991/ https://www.ncbi.nlm.nih.gov/pubmed/35937984 http://dx.doi.org/10.3389/fgene.2022.927046

Ejemplares similares

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of ALKBH7
por: Chen, Kaijie, et al.
Publicado: (2022)

Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer
por: Zhou, Xuan, et al.
Publicado: (2022)

Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target
por: Qie, Shuo, et al.
Publicado: (2022)

Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers
por: Zhu, Dong, et al.
Publicado: (2023)

Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells
por: He, Huocong, et al.
Publicado: (2019)

Stanniocalcin1 (STC1) Inhibits Cell Proliferation and Invasion of Cervical Cancer Cells
por: Guo, Fengjie, et al.
Publicado: (2013)

Stanniocalcin 2 (STC2) Expression Promotes Post-Radiation Survival, Migration and Invasion of Nasopharyngeal Carcinoma Cells [Corrigendum]
Publicado: (2019)

Sevoflurane inhibits the progression of ovarian cancer through down-regulating stanniocalcin 1 (STC1)
por: Zhang, Chuanfeng, et al.
Publicado: (2019)

Low Expression of Stanniocalcin 1 (STC-1) Protein Is Associated With Poor Clinicopathologic Features of Endometrial Cancer
por: Khatun, Masuma, et al.
Publicado: (2021)

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1
por: Dong, Shiqiang, et al.
Publicado: (2022)

Myriad Functions of Stanniocalcin-1 (STC1) Cover Multiple Therapeutic Targets in the Complicated Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)
por: Ohkouchi, Shinya, et al.
Publicado: (2015)

Pan-cancer analysis reveals the prognostic and immunotherapeutic value of cytoskeleton-associated protein 2-like
por: Yi, Bocun, et al.
Publicado: (2023)

FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy
por: Deng, Jiehua, et al.
Publicado: (2022)

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy
por: Lin, Zhengjun, et al.
Publicado: (2022)

Potential prognostic and immunotherapeutic value of calponin 1: A pan-cancer analysis
por: Zhou, Hengli, et al.
Publicado: (2023)

Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer
por: Yang, Kaixin, et al.
Publicado: (2022)

Stanniocalcin-1 (STC-1), a downstream effector molecule in latanoprost signaling, acts independent of the FP receptor for intraocular pressure reduction
por: Roddy, Gavin W., et al.
Publicado: (2020)

Prognostic value of high stanniocalcin 2 expression in solid cancers: A meta-analysis
por: Hu, Lixia, et al.
Publicado: (2019)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

SNHG17 Serves as an Oncogenic lncRNA by Regulating the miR-361-3p/STC2 Axis in Rectal Cancer
por: Huang, Fuda, et al.
Publicado: (2021)

Pan-cancer analyses reveal the immunotherapeutic value of klotho
por: Liang, Jinghao, et al.
Publicado: (2022)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

Prognostic and immunological role of SERPINH1 in pan-cancer
por: Zhong, Huage, et al.
Publicado: (2022)

Comprehensive analysis of the prognostic and immunotherapeutic implications of STAT family members in human colorectal cancer
por: Li, Dingchang, et al.
Publicado: (2022)

Stanniocalcin 1 is a prognostic biomarker in glioma
por: Luo, Weijian, et al.
Publicado: (2020)

Stanniocalcin2, but Not Stanniocalcin1, Responds to Hypoxia in a HIF1-Dependent Manner in the Retina
por: Ail, Divya, et al.
Publicado: (2022)

The significance of Stanniocalcin 2 in malignancies and mechanisms
por: Li, Shasha, et al.
Publicado: (2021)

Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction
por: Cediel, Germán, et al.
Publicado: (2018)

Research progress of STC2 in breast cancer
por: Niu, Xuezhi, et al.
Publicado: (2021)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)

A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of TOP1MT
por: Fei, Lihong, et al.
Publicado: (2022)

Oncogenetic Function and Prognostic Value of DNA Topoisomerase II Alpha in Human Malignances: A Pan-Cancer Analysis
por: Zhao, Fulai, et al.
Publicado: (2022)

A pan-cancer analysis of the prognostic value of long non-coding RNA LINC00662 in human cancers
por: Zhang, Guangming, et al.
Publicado: (2022)

Expression of Stanniocalcin-1 and Stanniocalcin-2 in Laryngeal Squamous Cell Carcinoma and Correlations with Clinical and Pathological Parameters
por: Zhou, Han, et al.
Publicado: (2014)

Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancer
por: Luo, Lianghua, et al.
Publicado: (2023)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Deng, Mingxia, et al.
Publicado: (2021)

An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer
por: Cong, Fengyun, et al.
Publicado: (2022)

A comprehensive analysis of G-protein-signaling modulator 2 as a prognostic and diagnostic marker for pan-cancer
por: Hu, Lei-Ming, et al.
Publicado: (2022)

PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
por: Huang, Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nea96qpc21mluct9nti4bfngor